Simulations Plus (SLP) Projected to Post Earnings on Thursday

Simulations Plus (NASDAQ:SLP) is anticipated to announce its Q3 2026 results after the market closes on Thursday, July 9th. Analysts expect the company to post earnings of $0.2325 per share and revenue of $20.8960 million for the quarter. Interested persons may visit the the company’s upcoming Q3 2026 earning overview page for the latest details on the call scheduled for Thursday, July 9, 2026 at 4:00 PM ET.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.08. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The company had revenue of $24.29 million during the quarter, compared to analysts’ expectations of $21.66 million.

Simulations Plus Stock Up 0.2%

Shares of NASDAQ SLP opened at $18.35 on Thursday. The stock’s 50 day moving average price is $16.04 and its two-hundred day moving average price is $15.50. Simulations Plus has a 52-week low of $11.09 and a 52-week high of $21.01. The stock has a market capitalization of $370.67 million, a P/E ratio of -5.86 and a beta of 1.30.

Institutional Trading of Simulations Plus

A number of institutional investors and hedge funds have recently made changes to their positions in SLP. Raymond James Financial Inc. acquired a new position in shares of Simulations Plus during the second quarter worth approximately $25,000. Quarry LP acquired a new stake in shares of Simulations Plus in the third quarter worth $28,000. US Bancorp DE raised its stake in Simulations Plus by 32.5% during the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock valued at $93,000 after purchasing an additional 1,513 shares during the last quarter. PharVision Advisers LLC bought a new stake in Simulations Plus in the 3rd quarter valued at $155,000. Finally, First Trust Advisors LP bought a new stake in Simulations Plus in the 3rd quarter valued at $167,000. Institutional investors and hedge funds own 78.08% of the company’s stock.

Analyst Ratings Changes

SLP has been the topic of a number of research analyst reports. Weiss Ratings raised Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, June 5th. William Blair downgraded shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a report on Wednesday, June 17th. Wall Street Zen lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price on the stock. in a research note on Thursday, June 18th. Finally, TD Cowen dropped their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 10th. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.90.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.